HI
ADPT icon

Horizon Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Horizon Investments’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,407
Closed -$167K – 531
2022
Q3 		$167K Buy
+23,407
New +$220K 0.01% 478
2022
Q2 		– Sell
-37,286
Closed -$518K – 461
2022
Q1 		$518K Buy
37,286
+6,406
+21% +$101K 0.01% 340
2021
Q4 		$866K Buy
30,880
+1,878
+6% +$57.6K 0.03% 228
2021
Q3 		$986K Buy
+29,002
New +$1.05M 0.03% 210

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Horizon Investments's ADPT Position: Q4 2022 in Review

Horizon Investments sold out of Adaptive Biotechnologies (ADPT) in Q4 2022, closing a stake of 23,407 shares — an estimated $167K sold.

Horizon Investments first reported a position in ADPT in Q3 2021 and held it in 4 quarters. The position peaked at $986K in Q3 2021. 223 funds tracked by Wall St. Rank hold ADPT as of Q4 2022.

  • Horizon Investments reported no remaining Adaptive Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • Horizon Investments sold 23,407 Adaptive Biotechnologies shares in Q4 2022, an estimated $167K.
  • Horizon Investments first reported a position in Adaptive Biotechnologies in Q3 2021 and held it in 4 quarters.
  • Horizon Investments's Adaptive Biotechnologies position peaked at $986K in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2022.

Based on Horizon Investments's 13F filing for Q4 2022, filed 14 Feb 2023.